Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Jan 15;11(2 Pt 1):421-8.

New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting

Nancy D Doolittle  1 , Lauren E Abrey, W Archie Bleyer, Steven Brem, Thomas P Davis, Paula Dore-Duffy, Lester R Drewes, Walter A Hall, John M Hoffman, Agnieszka Korfel, Robert Martuza, Leslie L Muldoon, David Peereboom, Darryl R Peterson, Samuel D Rabkin, Quentin Smith, Glen H J Stevens, Edward A Neuwelt
Affiliations
  • PMID: 15701824

New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting

Nancy D Doolittle et al. Clin Cancer Res. .

Abstract

The blood-brain barrier (BBB) presents a major obstacle to the treatment of malignant brain tumors and other central nervous system (CNS) diseases. For this reason, a meeting partially funded by an NIH R13 grant was convened to discuss recent advances and future directions in translational research in neuro-oncology and the BBB. Cell biology and transport across the BBB, delivery of agents to the CNS, neuroimaging, angiogenesis, immunotherapy, and gene therapy, as well as glioma, primary CNS lymphoma, and metastases to the CNS were discussed. Transport across the BBB relates to the neurovascular unit, which consists not only of endothelial cells but also of pericyte, glia, and neuronal elements.

PubMed Disclaimer

Publication types

LinkOut - more resources